Skip to main navigation Skip to search Skip to main content

Mapping SARS-CoV-2 antigenic relationships and serological responses

  • Samuel H. Wilks
  • , Barbara Mühlemann
  • , Xiaoying Shen
  • , Sina Türeli
  • , Eric B. LeGresley
  • , Antonia Netzl
  • , Miguela A. Caniza
  • , Jesus N. Chacaltana-Huarcaya
  • , Victor M. Corman
  • , Xiaoju Daniell
  • , Michael B. Datto
  • , Fatimah S. Dawood
  • , Thomas N. Denny
  • , Christian Drosten
  • , Ron A.M. Fouchier
  • , Patricia J. Garcia
  • , Peter J. Halfmann
  • , Agatha Jassem
  • , Lara M. Jeworowski
  • , Terry C. Jones
  • Yoshihiro Kawaoka, Florian Krammer, Charlene McDanal, Rolando Pajon, Viviana Simon, Melissa S. Stockwell, Haili Tang, Harm van Bakel, Vic Veguilla, Richard Webby, David C. Montefiori, Derek J. Smith
  • University of Cambridge
  • Berlin Institute of Health
  • Charité – Universitätsmedizin Berlin
  • Duke University School of Medicine
  • St. Jude Children's Research Hospital
  • Hospital Nacional Daniel Alcides Carrion
  • Centers for Disease Control and Prevention
  • Erasmus MC
  • University of Wisconsin–Madison
  • British Columbia Centre for Disease Control
  • University of Tokyo
  • National Center for Global Health
  • University of Tokyo
  • Icahn School of Medicine at Mount Sinai
  • Moderna Therapeutics
  • Columbia University

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Abstract

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)–1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection.

Original languageEnglish
Article numbereadj0070
JournalScience
Volume382
Issue number6666
DOIs
StatePublished - 6 Oct 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Mapping SARS-CoV-2 antigenic relationships and serological responses'. Together they form a unique fingerprint.

Cite this